SlideShare uma empresa Scribd logo
1 de 48
Baixar para ler offline
Rabeprazole 20 medical ppt
Rabe. 20
We will discuss
 GI system
 Acid secretion process
 Acid related disorders
 Treatment options & limitations
 Rabeprazole
Rabeprazole 20 medical ppt
The Stomach
The Stomach
Stomach consists of 3 parts viz. Fundus, Body
and Antrum. Stomach is the part of the GIT,
which produces Hydrochloric acid.
Functions of HCl are
1.Destroying the bacteria present in the food
2.Chemical breakdown of food
3.Activation of digestive enzyme
pepsin
The Stomach
FUNDUS: Food enters the upper section of the
stomach, called the FUNDUS.
Contains rugae folds to help with expansion when food
enters stomach, which the main function of the fundus.
BODY: It is the middle part of the stomach, which
follows after fundus. Food remains here for some
time, mixes with gastric juices and then forwarded to
the antrum.
The body of the stomach consists of majority of
secreting cells.
The Stomach
ANTRUM: The lower region of the stomach is called as
ANTRUM.
Grinds up swallowed food and regurgitates the
hydrochloric acid that is produced by the fundic and
body parietal cells.
Anatomy of Stomach
Stomach contain 5 types of Cells
Name of the Cell Function
Parietal Cell To Secrets HCL
G Cell To Secrets Gastrin
Chief Cell To Secrets Pepsin
Mast Cell To Secrets
Histamine
Mucus cell To Secrets Mucin
Acid Secretion
Acid secretion in the stomach is a continuous
process. Acid secretion is increased at the sight
or smell of food, at the meal times and during
stress.
Acid Secretion
There are 3 phases of acid secretion
1. Basal acid secretion: This secretion is devoid
of any stimulation and is governed by circadian
system of the body
2. Gastrin stimulated acid secretion: In this
phase, secretion is initiated by the presence of
food in stomach, sight, smell or even thought
of food.
Acid Secretion
3. Histamine stimulated acid secretion: Mast cells
secrete histamine. Stress and tensions
influence secretion of histamine. This secretion
is controlled by vagal stimulation.
 Vagal stimulation also releases acetylcholine.
These in turn stimulate histamine (H2) and
muscarinic receptors respectively present on
the parietal cells leading to increased gastric
acid secretion.
Formation of HCL
Role of HCL
 Strongly acidic fluid - Kills many microbes in food
 Stimulates the secretion of hormones that promote the flow of
bile and pancreatic juice.
 It is required for digestion of Proteins.
 Chemical breakdown of food.
 Create an environment for absorption of Nutrients, Vitamin
B12 and calcium.
Altered acid physiology & consequences
A mismatch between aggressive forces (mainly acid
and pepsin) and defensive forces (mucosal integrity) is
responsible for various acid related disorders. This
mismatch can occur because of
 Increased acid secretion, and/or
 Decreased mucosal defenses like-
1. Mucus
2. Mucosal blood flow
3. Bicarbonate
4. Cell renewal
5. Endogenous prostaglandins
Gastric Acid Pathogenesis
 Gastric acid plays a pivotal role in the pathogenesis of various acid
related disorders or acid-peptic disorders, including
 Reflux Esophagistis
 Non-erosive reflux disease
 Gastro Esophageal Reflux Disease
 Non-cardiac chest pain
 NSAID Induced gastritis
 Peptic Ulcers
 Functional Dyspepsia
 pathologic gastrointestinal hypersecretory conditions
Reflux Esophagistis
 Reflux esophagitis is better known as “heartburn.”
 It is often felt behind the breastbone as a burning
chest discomfort, feeling of food coming back into the
mouth as an acid or bitter taste.
 It mostly happens after meals and last a couple of
minutes to a couple of hours. It may not be relieved by
rest nor be caused by exercise, and may become worse
if you lie flat or bend over.
Symptoms
 Bad taste in the mouth
 Loss of tooth enamel
 Chronic sore throat
 Hoarseness
 Choking
 Cough or wheezing
Complications of Reflux Esophagistis
 If RE is not treated, the inflamed area may bleed
slowly. Too much blood loss may cause low blood
count.
 Damage to the lower esophagus may also cause scars to
form. Too much scarring causes the lower end of the
esophagus to narrow, making it harder and harder to
swallow.
 Some patients with severe scarring may have trouble
swallowing.
Complications of Reflux Esophagistis
 Barrett esophagus: sometimes called Barrett syndrome
or columnar epithelium lined lower oesophagus
(CELLO), refers to an abnormal change in the cells of the
lower portion of esophagus.
 When the normal squamous epithelium lining of the
esophagus is replaced by goblet cells (cells usually found
lower in the gastrointestinal tract), Barrett's esophagus is
diagnosed.
 A small number of people with Barrett’s esophagus
develop a rare but often deadly type of cancer of the
esophagus.
Gastro Esophageal Reflux Disease
 Gastro Esophageal Reflux Disease is the result of the
reflux of gastric contents into the esophagus such an
extent that it overcomes the mucosal defense and
causes injury to the esophageal mucosa
Factors causing reflux and contribution to GERD
 LES Related Disorder
1. A mechanical defect in LES
2. Inappropriate transient relaxation of LES
3. Hiatal hernia (also provides a reservoir for acid)
 Type of food
1. Fatty and/or spicy food eating habit
2. Coffee, citrus or tomato juices
Factors causing reflux and contribute to GERD
 Increased Gastric Pressure
1. Delayed gastric emptying
2. Obesity
3. Pregnancy
 Others
1. Certain medications
2. Smoking
Sometimes if pylorus is impaired, bile and other
duodenal contents reflux from duodenum to
stomach and to esophagus adding aggravation
GERD.
GERD Symptoms
Intermittent substernal burning of pain (heartburn) is
characteristic of GERD. Other symptoms include
1. Angina-like chest pain
2. Laryngitis
3. Hoarseness
4. Chronic cough
5. Bronchitis
6. Aspiration pneumonia
Non-erosive reflux disease
 NERD is defined as the presence of classic GERD
symptoms in the absence of esophageal mucosal
injury.
Symptoms
 persistent heartburn
 acid regurgitation
 Nausea
 Hoarseness in the morning or trouble swallowing
 May feel like food is stuck in the throat
 Bad breath
 Persistent dry cough
but they do not have visible esophageal injury.
Non-cardiac chest pain
 When acid from the stomach flows up into the
esophagus, it can cause a burning sensation in the
chest that's often mistaken for angina or a heart attack
 Because the pain is similar to heart pain (called
angina), patients present to emergency rooms
concerned about a heart attack and commonly
undergo cardiac tests). After these cardiac tests fail to
show evidence of heart disease, the patients receive
the diagnosis of NCCP.
Symptoms
 Non-cardiac chest pain typically is felt behind the
breast bone (sternum) and is described as
oppressive, squeezing or pressure-like. It may radiate
to the neck, left arm or the back (the spine). It may be
precipitated by food intake.
 Heartburn
 Fluid regurgitation
 Bitter or sour taste
Functional Dyspepsia
 Functional Dyspepsia defined as discomfort or pain in
the upper part of the abdomen.
Symptoms
 postprandial fullness and bloating
 Epigastric pain
 Early satiety
 Nausea
 Belching
Peptic Ulcer
 The two major risk factors known to impair
mucosal defenses and lead to peptic ulcers are
bacterium Helicobacter pylori (H. pylori) and the
frequent use of NSAIDs.
 Gastric acid, further, contributes to formation of
ulcers once mucosal defenses are impaired. But
acid usually does not cause ulcers independently.
Helicobacter pylori
 The risk of PUD is up to seven times higher in
patients with H. pylori infection than in general
population.
 More than 70% of patients with gastric ulcers and
more than 90% of patients with duodenal ulcers are
infected with H. pylori.
 H. pylori is thought to damage the gastric mucosa.
Symptoms of PU
 Main symptom is dull aching or gnawing epigastric pain or
burning 1 to 3 hours after eating as per the location of
ulcer.
 It is often relieved by eating or by antacids. Pain may
worsen in night because of increased acid secretion and
lack of food material in stomach to dilute the acid.
 The nighttime paid normally interferes with sleep. Nausea,
vomiting and bloating are the other symptoms.
Complications of PU
 Bleeding ulcers
 Perforation into the peritoneal cavity
 Penetration into adjacent organs
 Gastric/intestinal passage obstruction
NSAIDs Induced gastritis
Non Steroidal Anti-inflammatory Drugs NSAIDs
damage the GI mucosa by dual mechanism.
1. They cause direct irritation to GI mucosa.
2. They inhibit prostaglandin synthesis leading to
reduced mucosal integrity & mucosal defense.
The acid then contributes to formation of ulcers. Use
of NSAIDs increases the risk of PUD upto 20 fold.
pathologic gastrointestinal hypersecretory
conditions
 Gastric acid secretion is largely control by
cholinergic, histaminergic and
peptidinergic(especially gastrin) pathways. Disorders
in a number of these pathways can lead to gastric acid
hypersecretion.
Classification of gastric acid hypersecretory state
 associated with hypergastrinemia
 associated with hyperhistaminemia
 unknown etiology
Zollinger-Ellison Syndrome
 ZES is a clinical syndrome characterized primarily by
refractory peptic ulcer disease which is due to ectopic
release of gastrin by gastrinoma resulting in gastric
acid hypersecretion.
 Complications of Zollinger-Ellison Syndrome
 A person who has Zollinger-Ellison syndrome may
have only one gastrinoma or may have several
 In some ZES patient gastrinomas may be malignant
(cancerous)
Symptoms
 Burning pain in the abdomen
 Nausea
 Diarrhea
 Vomiting
 Bleeding from the stomach
 Weakness
 Fatigue
Pharmacotherapy for Acid Suppression
Different medications are available to inhibit the acids.
 ANTACIDS
 Histamine H2-Receptor Antagonists
 Proton Pump Inhibitors
Limitation of Antacids
 Antacids relieve the symptoms but cannot healing in
recommended dosage
 Have short duration of action (about 2 hours) and need frequent
dosing
 Antacids are ineffective for eradication H. pylori
 Rebound acid secretion phenomenon may be problematic
 Adverse effects (constipation with aluminum salts and diarrhea
with magnesium salts)
 Drug interactions
 Hampered absorption of other drugs because of change in pH
Limitations of H2-Receptor Antagonists
 Controls mainly histamine related acid secretions and has
very low efficacy in gastrin related secretions
 Recurrence rate is high in patients with H. pylori infection
 Healing is delayed in smokers and recurrence rate is high
 May interact with other medications
 Though generally well tolerated, H2-Receptor
Antagonists can cause headache and other side4 effects
like confusion, diarrhea & gynecomastia (with
cimetidine).
Proton Pump Inhibitors
 Proton Pump inhibitors were introduced in late 1980s.
 Proton Pump inhibitors bind to the Proton Pump on
parietal cell and inhibit the acid secretion regardless of
whether it is stimulated by histamine, acetylcholine or
gastrin.
 Proton Pump Inhibitors also have in vitro antimicrobial
activity against H. pylori though they cannot eradicate
H. pylori when used alone.
P.P.I. -
1. OMEPRAZOLE……1988
2. LANSOPRAZOLE…1991
3. PANTOPRAZOLE …1994
4. RABEPRAZOLE…..1999
Are all PPI’s the same..????
Comparison of all PPI
 All PPIs are effective in healing and maintenance of
ARD but they differ in their ability to control
symptoms rapidly and consistently
 Rabeprazole is different from other PPI because of
more rapid rate of activation, Rabeprazole results in a
faster onset of action and faster symptoms control
than other PPIs
Comparison of all PPI
Pharmacokinetic Profiles
Pharmacodynamic
Parameter
Lansoprazole Omeprazole Rabeprazole
At a pH of 1.2 2 2.8 1.3
At a pH of 5.1 90 84 7.2
At 10min 66% 47% 100%
At 45 Min 100% 83% 100%
Activation Time(min)
% Inhibition of the H+/K+-ATPase
Comparison of all PPI
 Food does not affect degree of absorption
 Rabeprazole, involving both cytochrome P450
mediated reaction in the liver and nonenzymatic
reactions, appears to confer an advantage over other
PPIs
Rabe.. 20
Indications:
 Reflux Esophagistis
 Non-erosive reflux disease
 Non-cardiac chest pain
 NSAID Induced gastritis
 Peptic Ulcers
 Functional Dyspepsia
Rabe… 20
Dosage and Administration
 20 OD for 4 to 8 weeks
 And in complicated ARD up to 40 mg for 4 to 8 weeks
Rabe…20
USPs
 The latest and potent PPI
 Maximum speed of onset of action
 Maximum acid control
 Maximum gastroprotection
 Greater and faster symptom relief
 Safe and convenient

Mais conteúdo relacionado

Mais procurados

Presentation On ‘‘Esomeprazole’’
Presentation On ‘‘Esomeprazole’’Presentation On ‘‘Esomeprazole’’
Presentation On ‘‘Esomeprazole’’Anm Sharif
 
Talk on gastic disorders and rabeprazole
Talk on gastic disorders and rabeprazoleTalk on gastic disorders and rabeprazole
Talk on gastic disorders and rabeprazoleDr. ANSHU GOKARN
 
Drugs for Peptic Ulcer
Drugs for Peptic UlcerDrugs for Peptic Ulcer
Drugs for Peptic UlcerDr Vinay Gupta
 
Current Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseCurrent Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseAadil Sayyed
 
Esomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeEsomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeMehedee Hasan
 
Advance Gerd Voniza Presenatation.pptx
Advance Gerd Voniza Presenatation.pptxAdvance Gerd Voniza Presenatation.pptx
Advance Gerd Voniza Presenatation.pptxDrGhulamRasool1
 
Pharmacology of Gastrointestinal Diseases
Pharmacology of Gastrointestinal DiseasesPharmacology of Gastrointestinal Diseases
Pharmacology of Gastrointestinal DiseasesGanapathy Tamilselvan
 
Proton Pump Inhibitor (PPI)
Proton Pump Inhibitor (PPI)Proton Pump Inhibitor (PPI)
Proton Pump Inhibitor (PPI)Md. Saiful Islam
 
Proton pump inhibitor
Proton pump inhibitorProton pump inhibitor
Proton pump inhibitorAsiful alam
 
Esdom (Esomeprazole 40mg + Domperidone 30 mg)
Esdom (Esomeprazole 40mg + Domperidone 30 mg)Esdom (Esomeprazole 40mg + Domperidone 30 mg)
Esdom (Esomeprazole 40mg + Domperidone 30 mg)Nadia Qayyum
 
Proton pump inhibitors
Proton pump inhibitors Proton pump inhibitors
Proton pump inhibitors Aditi Kaushik
 
Acid peptic disease 1
Acid peptic disease 1Acid peptic disease 1
Acid peptic disease 1Prem Chand
 
Pharmacology of Gastrointestinal Disorders
Pharmacology of Gastrointestinal Disorders  Pharmacology of Gastrointestinal Disorders
Pharmacology of Gastrointestinal Disorders dineshmeena53
 

Mais procurados (20)

Presentation On ‘‘Esomeprazole’’
Presentation On ‘‘Esomeprazole’’Presentation On ‘‘Esomeprazole’’
Presentation On ‘‘Esomeprazole’’
 
Talk on gastic disorders and rabeprazole
Talk on gastic disorders and rabeprazoleTalk on gastic disorders and rabeprazole
Talk on gastic disorders and rabeprazole
 
Drugs for Peptic Ulcer
Drugs for Peptic UlcerDrugs for Peptic Ulcer
Drugs for Peptic Ulcer
 
Current Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux DiseaseCurrent Trends in Management of Gastroesophageal Reflux Disease
Current Trends in Management of Gastroesophageal Reflux Disease
 
Stomach
StomachStomach
Stomach
 
Esomeprazole product presentation
Esomeprazole product presentationEsomeprazole product presentation
Esomeprazole product presentation
 
Esomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedeeEsomeprazole marketing plan by mehedee
Esomeprazole marketing plan by mehedee
 
proton pump inhibitors PPT
proton pump inhibitors PPTproton pump inhibitors PPT
proton pump inhibitors PPT
 
Lactulose branding
Lactulose brandingLactulose branding
Lactulose branding
 
Advance Gerd Voniza Presenatation.pptx
Advance Gerd Voniza Presenatation.pptxAdvance Gerd Voniza Presenatation.pptx
Advance Gerd Voniza Presenatation.pptx
 
Pharmacology of Gastrointestinal Diseases
Pharmacology of Gastrointestinal DiseasesPharmacology of Gastrointestinal Diseases
Pharmacology of Gastrointestinal Diseases
 
Proton Pump Inhibitors
Proton Pump InhibitorsProton Pump Inhibitors
Proton Pump Inhibitors
 
Proton Pump Inhibitor (PPI)
Proton Pump Inhibitor (PPI)Proton Pump Inhibitor (PPI)
Proton Pump Inhibitor (PPI)
 
Omeprazole
OmeprazoleOmeprazole
Omeprazole
 
Proton pump inhibitor
Proton pump inhibitorProton pump inhibitor
Proton pump inhibitor
 
Esdom (Esomeprazole 40mg + Domperidone 30 mg)
Esdom (Esomeprazole 40mg + Domperidone 30 mg)Esdom (Esomeprazole 40mg + Domperidone 30 mg)
Esdom (Esomeprazole 40mg + Domperidone 30 mg)
 
Prucalopride
PrucalopridePrucalopride
Prucalopride
 
Proton pump inhibitors
Proton pump inhibitors Proton pump inhibitors
Proton pump inhibitors
 
Acid peptic disease 1
Acid peptic disease 1Acid peptic disease 1
Acid peptic disease 1
 
Pharmacology of Gastrointestinal Disorders
Pharmacology of Gastrointestinal Disorders  Pharmacology of Gastrointestinal Disorders
Pharmacology of Gastrointestinal Disorders
 

Destaque

Gastroesophageal reflux disorder- GERD
Gastroesophageal reflux disorder- GERDGastroesophageal reflux disorder- GERD
Gastroesophageal reflux disorder- GERDSelvaraj Balasubramani
 
Centrally Acting Antispastic Drugs
Centrally Acting Antispastic DrugsCentrally Acting Antispastic Drugs
Centrally Acting Antispastic Drugswendwesen alemu
 
Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Claudio Melloni
 
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst Excision
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst ExcisionSuccinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst Excision
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst ExcisionApollo Hospitals
 
Intrathecal baclofen
Intrathecal baclofenIntrathecal baclofen
Intrathecal baclofentcrumph2
 
Baclofen low back pain | Muhammad Nizam Uddin
Baclofen low back pain | Muhammad Nizam UddinBaclofen low back pain | Muhammad Nizam Uddin
Baclofen low back pain | Muhammad Nizam UddinMuhammad Nizam Uddin
 
Muscle Relaxants
Muscle RelaxantsMuscle Relaxants
Muscle RelaxantsKhalid
 
Neuromuscular blocking agents
Neuromuscular blocking agentsNeuromuscular blocking agents
Neuromuscular blocking agentsDrJagadish Jena
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersPranav Bansal
 
Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockersraj kumar
 

Destaque (15)

Gastroesophageal reflux disorder- GERD
Gastroesophageal reflux disorder- GERDGastroesophageal reflux disorder- GERD
Gastroesophageal reflux disorder- GERD
 
Zee ppt gerd
Zee ppt gerdZee ppt gerd
Zee ppt gerd
 
Centrally Acting Antispastic Drugs
Centrally Acting Antispastic DrugsCentrally Acting Antispastic Drugs
Centrally Acting Antispastic Drugs
 
Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation Ryanodex,a new dantrolene formulation
Ryanodex,a new dantrolene formulation
 
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst Excision
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst ExcisionSuccinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst Excision
Succinylcholine Apnea in an Unusual Case Posted for Dentigerous Cyst Excision
 
Intrathecal baclofen
Intrathecal baclofenIntrathecal baclofen
Intrathecal baclofen
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
Baclofen low back pain | Muhammad Nizam Uddin
Baclofen low back pain | Muhammad Nizam UddinBaclofen low back pain | Muhammad Nizam Uddin
Baclofen low back pain | Muhammad Nizam Uddin
 
Neuromuscular blocking
Neuromuscular blockingNeuromuscular blocking
Neuromuscular blocking
 
Muscle Relaxants
Muscle RelaxantsMuscle Relaxants
Muscle Relaxants
 
Neuromuscular blocking agents
Neuromuscular blocking agentsNeuromuscular blocking agents
Neuromuscular blocking agents
 
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockersSkeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
Skeletal muscle relaxants, Neuromuscular blocking agents, Neuromuscular blockers
 
Skeletal Muscle Relaxants
Skeletal Muscle RelaxantsSkeletal Muscle Relaxants
Skeletal Muscle Relaxants
 
Neuro muscular blockers
Neuro muscular blockersNeuro muscular blockers
Neuro muscular blockers
 
Skeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhritiSkeletal muscle relaxants - drdhriti
Skeletal muscle relaxants - drdhriti
 

Semelhante a Rabeprazole 20 medical ppt

Presentation IBS & GERD
Presentation IBS & GERDPresentation IBS & GERD
Presentation IBS & GERDckapaale
 
Physio Gi 11,12.
Physio Gi 11,12.Physio Gi 11,12.
Physio Gi 11,12.Shaikhani.
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Dr. Kiran Dhamak
 
Physio git pathophysiology plus mc qs.
Physio git pathophysiology plus mc qs.Physio git pathophysiology plus mc qs.
Physio git pathophysiology plus mc qs.Shaikhani.
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxSudipta Roy
 
Pud Gastritis Lecture[1]
Pud Gastritis Lecture[1]Pud Gastritis Lecture[1]
Pud Gastritis Lecture[1]Miami Dade
 
Acid Reflux Disease Research Paper
Acid Reflux Disease Research PaperAcid Reflux Disease Research Paper
Acid Reflux Disease Research PaperAmber Wheeler
 
Management of tuberculosis
Management of tuberculosis Management of tuberculosis
Management of tuberculosis MuniraMkamba
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders Uma Binoy
 
4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptxmonthjanuary662
 
Motility OF SMALL INTESTINE, Malabsorbtion and diarrhoea.pptx
Motility OF SMALL INTESTINE, Malabsorbtion      and diarrhoea.pptxMotility OF SMALL INTESTINE, Malabsorbtion      and diarrhoea.pptx
Motility OF SMALL INTESTINE, Malabsorbtion and diarrhoea.pptxWallerianDegenration
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxSudipta Roy
 

Semelhante a Rabeprazole 20 medical ppt (20)

regurgitation
regurgitationregurgitation
regurgitation
 
Presentation IBS & GERD
Presentation IBS & GERDPresentation IBS & GERD
Presentation IBS & GERD
 
Physio Gi 11,12.
Physio Gi 11,12.Physio Gi 11,12.
Physio Gi 11,12.
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
 
Physio git pathophysiology plus mc qs.
Physio git pathophysiology plus mc qs.Physio git pathophysiology plus mc qs.
Physio git pathophysiology plus mc qs.
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptx
 
Pud Gastritis Lecture[1]
Pud Gastritis Lecture[1]Pud Gastritis Lecture[1]
Pud Gastritis Lecture[1]
 
GIT disorder
GIT disorderGIT disorder
GIT disorder
 
1. Gastritis.pptx
1. Gastritis.pptx1. Gastritis.pptx
1. Gastritis.pptx
 
Acid Reflux Disease Research Paper
Acid Reflux Disease Research PaperAcid Reflux Disease Research Paper
Acid Reflux Disease Research Paper
 
Au med
Au medAu med
Au med
 
final copy
final copyfinal copy
final copy
 
Peptic ulcer
Peptic ulcerPeptic ulcer
Peptic ulcer
 
Reflux
RefluxReflux
Reflux
 
Management of tuberculosis
Management of tuberculosis Management of tuberculosis
Management of tuberculosis
 
Stomach disorders
Stomach disorders Stomach disorders
Stomach disorders
 
4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx4) PEPTIC ULCERS-Power Point-1.pptx
4) PEPTIC ULCERS-Power Point-1.pptx
 
Motility OF SMALL INTESTINE, Malabsorbtion and diarrhoea.pptx
Motility OF SMALL INTESTINE, Malabsorbtion      and diarrhoea.pptxMotility OF SMALL INTESTINE, Malabsorbtion      and diarrhoea.pptx
Motility OF SMALL INTESTINE, Malabsorbtion and diarrhoea.pptx
 
Gastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptxGastro Oesophagal Reflux Disease GERD.pptx
Gastro Oesophagal Reflux Disease GERD.pptx
 
Peptic ulcer disease final
Peptic ulcer disease final Peptic ulcer disease final
Peptic ulcer disease final
 

Último

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu Medical University
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectiondrhanifmohdali
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...Sujoy Dasgupta
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsMedicoseAcademics
 

Último (20)

power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Mental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil ThirusanguMental health Team. Dr Senthil Thirusangu
Mental health Team. Dr Senthil Thirusangu
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
AORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissectionAORTIC DISSECTION and management of aortic dissection
AORTIC DISSECTION and management of aortic dissection
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio..."Radical excision of DIE in subferile women with deep infiltrating endometrio...
"Radical excision of DIE in subferile women with deep infiltrating endometrio...
 
AUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functionsAUTONOMIC NERVOUS SYSTEM organization and functions
AUTONOMIC NERVOUS SYSTEM organization and functions
 

Rabeprazole 20 medical ppt

  • 2. Rabe. 20 We will discuss  GI system  Acid secretion process  Acid related disorders  Treatment options & limitations  Rabeprazole
  • 5. The Stomach Stomach consists of 3 parts viz. Fundus, Body and Antrum. Stomach is the part of the GIT, which produces Hydrochloric acid. Functions of HCl are 1.Destroying the bacteria present in the food 2.Chemical breakdown of food 3.Activation of digestive enzyme pepsin
  • 6. The Stomach FUNDUS: Food enters the upper section of the stomach, called the FUNDUS. Contains rugae folds to help with expansion when food enters stomach, which the main function of the fundus. BODY: It is the middle part of the stomach, which follows after fundus. Food remains here for some time, mixes with gastric juices and then forwarded to the antrum. The body of the stomach consists of majority of secreting cells.
  • 7. The Stomach ANTRUM: The lower region of the stomach is called as ANTRUM. Grinds up swallowed food and regurgitates the hydrochloric acid that is produced by the fundic and body parietal cells.
  • 8. Anatomy of Stomach Stomach contain 5 types of Cells Name of the Cell Function Parietal Cell To Secrets HCL G Cell To Secrets Gastrin Chief Cell To Secrets Pepsin Mast Cell To Secrets Histamine Mucus cell To Secrets Mucin
  • 9. Acid Secretion Acid secretion in the stomach is a continuous process. Acid secretion is increased at the sight or smell of food, at the meal times and during stress.
  • 10. Acid Secretion There are 3 phases of acid secretion 1. Basal acid secretion: This secretion is devoid of any stimulation and is governed by circadian system of the body 2. Gastrin stimulated acid secretion: In this phase, secretion is initiated by the presence of food in stomach, sight, smell or even thought of food.
  • 11. Acid Secretion 3. Histamine stimulated acid secretion: Mast cells secrete histamine. Stress and tensions influence secretion of histamine. This secretion is controlled by vagal stimulation.  Vagal stimulation also releases acetylcholine. These in turn stimulate histamine (H2) and muscarinic receptors respectively present on the parietal cells leading to increased gastric acid secretion.
  • 13. Role of HCL  Strongly acidic fluid - Kills many microbes in food  Stimulates the secretion of hormones that promote the flow of bile and pancreatic juice.  It is required for digestion of Proteins.  Chemical breakdown of food.  Create an environment for absorption of Nutrients, Vitamin B12 and calcium.
  • 14. Altered acid physiology & consequences A mismatch between aggressive forces (mainly acid and pepsin) and defensive forces (mucosal integrity) is responsible for various acid related disorders. This mismatch can occur because of  Increased acid secretion, and/or  Decreased mucosal defenses like- 1. Mucus 2. Mucosal blood flow 3. Bicarbonate 4. Cell renewal 5. Endogenous prostaglandins
  • 15. Gastric Acid Pathogenesis  Gastric acid plays a pivotal role in the pathogenesis of various acid related disorders or acid-peptic disorders, including  Reflux Esophagistis  Non-erosive reflux disease  Gastro Esophageal Reflux Disease  Non-cardiac chest pain  NSAID Induced gastritis  Peptic Ulcers  Functional Dyspepsia  pathologic gastrointestinal hypersecretory conditions
  • 16. Reflux Esophagistis  Reflux esophagitis is better known as “heartburn.”  It is often felt behind the breastbone as a burning chest discomfort, feeling of food coming back into the mouth as an acid or bitter taste.  It mostly happens after meals and last a couple of minutes to a couple of hours. It may not be relieved by rest nor be caused by exercise, and may become worse if you lie flat or bend over.
  • 17. Symptoms  Bad taste in the mouth  Loss of tooth enamel  Chronic sore throat  Hoarseness  Choking  Cough or wheezing
  • 18. Complications of Reflux Esophagistis  If RE is not treated, the inflamed area may bleed slowly. Too much blood loss may cause low blood count.  Damage to the lower esophagus may also cause scars to form. Too much scarring causes the lower end of the esophagus to narrow, making it harder and harder to swallow.  Some patients with severe scarring may have trouble swallowing.
  • 19. Complications of Reflux Esophagistis  Barrett esophagus: sometimes called Barrett syndrome or columnar epithelium lined lower oesophagus (CELLO), refers to an abnormal change in the cells of the lower portion of esophagus.  When the normal squamous epithelium lining of the esophagus is replaced by goblet cells (cells usually found lower in the gastrointestinal tract), Barrett's esophagus is diagnosed.  A small number of people with Barrett’s esophagus develop a rare but often deadly type of cancer of the esophagus.
  • 20. Gastro Esophageal Reflux Disease  Gastro Esophageal Reflux Disease is the result of the reflux of gastric contents into the esophagus such an extent that it overcomes the mucosal defense and causes injury to the esophageal mucosa
  • 21. Factors causing reflux and contribution to GERD  LES Related Disorder 1. A mechanical defect in LES 2. Inappropriate transient relaxation of LES 3. Hiatal hernia (also provides a reservoir for acid)  Type of food 1. Fatty and/or spicy food eating habit 2. Coffee, citrus or tomato juices
  • 22. Factors causing reflux and contribute to GERD  Increased Gastric Pressure 1. Delayed gastric emptying 2. Obesity 3. Pregnancy  Others 1. Certain medications 2. Smoking Sometimes if pylorus is impaired, bile and other duodenal contents reflux from duodenum to stomach and to esophagus adding aggravation GERD.
  • 23. GERD Symptoms Intermittent substernal burning of pain (heartburn) is characteristic of GERD. Other symptoms include 1. Angina-like chest pain 2. Laryngitis 3. Hoarseness 4. Chronic cough 5. Bronchitis 6. Aspiration pneumonia
  • 24. Non-erosive reflux disease  NERD is defined as the presence of classic GERD symptoms in the absence of esophageal mucosal injury.
  • 25. Symptoms  persistent heartburn  acid regurgitation  Nausea  Hoarseness in the morning or trouble swallowing  May feel like food is stuck in the throat  Bad breath  Persistent dry cough but they do not have visible esophageal injury.
  • 26. Non-cardiac chest pain  When acid from the stomach flows up into the esophagus, it can cause a burning sensation in the chest that's often mistaken for angina or a heart attack  Because the pain is similar to heart pain (called angina), patients present to emergency rooms concerned about a heart attack and commonly undergo cardiac tests). After these cardiac tests fail to show evidence of heart disease, the patients receive the diagnosis of NCCP.
  • 27. Symptoms  Non-cardiac chest pain typically is felt behind the breast bone (sternum) and is described as oppressive, squeezing or pressure-like. It may radiate to the neck, left arm or the back (the spine). It may be precipitated by food intake.  Heartburn  Fluid regurgitation  Bitter or sour taste
  • 28. Functional Dyspepsia  Functional Dyspepsia defined as discomfort or pain in the upper part of the abdomen.
  • 29. Symptoms  postprandial fullness and bloating  Epigastric pain  Early satiety  Nausea  Belching
  • 30. Peptic Ulcer  The two major risk factors known to impair mucosal defenses and lead to peptic ulcers are bacterium Helicobacter pylori (H. pylori) and the frequent use of NSAIDs.  Gastric acid, further, contributes to formation of ulcers once mucosal defenses are impaired. But acid usually does not cause ulcers independently.
  • 31. Helicobacter pylori  The risk of PUD is up to seven times higher in patients with H. pylori infection than in general population.  More than 70% of patients with gastric ulcers and more than 90% of patients with duodenal ulcers are infected with H. pylori.  H. pylori is thought to damage the gastric mucosa.
  • 32. Symptoms of PU  Main symptom is dull aching or gnawing epigastric pain or burning 1 to 3 hours after eating as per the location of ulcer.  It is often relieved by eating or by antacids. Pain may worsen in night because of increased acid secretion and lack of food material in stomach to dilute the acid.  The nighttime paid normally interferes with sleep. Nausea, vomiting and bloating are the other symptoms.
  • 33. Complications of PU  Bleeding ulcers  Perforation into the peritoneal cavity  Penetration into adjacent organs  Gastric/intestinal passage obstruction
  • 34. NSAIDs Induced gastritis Non Steroidal Anti-inflammatory Drugs NSAIDs damage the GI mucosa by dual mechanism. 1. They cause direct irritation to GI mucosa. 2. They inhibit prostaglandin synthesis leading to reduced mucosal integrity & mucosal defense. The acid then contributes to formation of ulcers. Use of NSAIDs increases the risk of PUD upto 20 fold.
  • 35. pathologic gastrointestinal hypersecretory conditions  Gastric acid secretion is largely control by cholinergic, histaminergic and peptidinergic(especially gastrin) pathways. Disorders in a number of these pathways can lead to gastric acid hypersecretion. Classification of gastric acid hypersecretory state  associated with hypergastrinemia  associated with hyperhistaminemia  unknown etiology
  • 36. Zollinger-Ellison Syndrome  ZES is a clinical syndrome characterized primarily by refractory peptic ulcer disease which is due to ectopic release of gastrin by gastrinoma resulting in gastric acid hypersecretion.  Complications of Zollinger-Ellison Syndrome  A person who has Zollinger-Ellison syndrome may have only one gastrinoma or may have several  In some ZES patient gastrinomas may be malignant (cancerous)
  • 37. Symptoms  Burning pain in the abdomen  Nausea  Diarrhea  Vomiting  Bleeding from the stomach  Weakness  Fatigue
  • 38. Pharmacotherapy for Acid Suppression Different medications are available to inhibit the acids.  ANTACIDS  Histamine H2-Receptor Antagonists  Proton Pump Inhibitors
  • 39. Limitation of Antacids  Antacids relieve the symptoms but cannot healing in recommended dosage  Have short duration of action (about 2 hours) and need frequent dosing  Antacids are ineffective for eradication H. pylori  Rebound acid secretion phenomenon may be problematic  Adverse effects (constipation with aluminum salts and diarrhea with magnesium salts)  Drug interactions  Hampered absorption of other drugs because of change in pH
  • 40. Limitations of H2-Receptor Antagonists  Controls mainly histamine related acid secretions and has very low efficacy in gastrin related secretions  Recurrence rate is high in patients with H. pylori infection  Healing is delayed in smokers and recurrence rate is high  May interact with other medications  Though generally well tolerated, H2-Receptor Antagonists can cause headache and other side4 effects like confusion, diarrhea & gynecomastia (with cimetidine).
  • 41. Proton Pump Inhibitors  Proton Pump inhibitors were introduced in late 1980s.  Proton Pump inhibitors bind to the Proton Pump on parietal cell and inhibit the acid secretion regardless of whether it is stimulated by histamine, acetylcholine or gastrin.  Proton Pump Inhibitors also have in vitro antimicrobial activity against H. pylori though they cannot eradicate H. pylori when used alone.
  • 42. P.P.I. - 1. OMEPRAZOLE……1988 2. LANSOPRAZOLE…1991 3. PANTOPRAZOLE …1994 4. RABEPRAZOLE…..1999 Are all PPI’s the same..????
  • 43. Comparison of all PPI  All PPIs are effective in healing and maintenance of ARD but they differ in their ability to control symptoms rapidly and consistently  Rabeprazole is different from other PPI because of more rapid rate of activation, Rabeprazole results in a faster onset of action and faster symptoms control than other PPIs
  • 44. Comparison of all PPI Pharmacokinetic Profiles Pharmacodynamic Parameter Lansoprazole Omeprazole Rabeprazole At a pH of 1.2 2 2.8 1.3 At a pH of 5.1 90 84 7.2 At 10min 66% 47% 100% At 45 Min 100% 83% 100% Activation Time(min) % Inhibition of the H+/K+-ATPase
  • 45. Comparison of all PPI  Food does not affect degree of absorption  Rabeprazole, involving both cytochrome P450 mediated reaction in the liver and nonenzymatic reactions, appears to confer an advantage over other PPIs
  • 46. Rabe.. 20 Indications:  Reflux Esophagistis  Non-erosive reflux disease  Non-cardiac chest pain  NSAID Induced gastritis  Peptic Ulcers  Functional Dyspepsia
  • 47. Rabe… 20 Dosage and Administration  20 OD for 4 to 8 weeks  And in complicated ARD up to 40 mg for 4 to 8 weeks
  • 48. Rabe…20 USPs  The latest and potent PPI  Maximum speed of onset of action  Maximum acid control  Maximum gastroprotection  Greater and faster symptom relief  Safe and convenient